ORGO: Organogenesis Holdings Inc. Stock

by  •  • Comments Off on ORGO: Organogenesis Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 323.97
Enterprise Value ($M) 286.36
Book Value ($M) 278.66
Book Value / Share 2.11
Price / Book 1.16
NCAV ($M) 43.68
NCAV / Share 0.33
Price / NCAV 7.42

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 2.44
Current Ratio 2.80

Balance Sheet (mrq) ($M)
Current Assets 225.04
Assets 460.02
Liabilities 181.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 433.14
Operating Income 16.32
Net Income 4.95
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 30.92
Cash from Investing -24.36
Cash from Financing -5.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-09 13G Morgan Stanley 8.70
02-02 13G/A Soleus Capital Master Fund, L.P. 6.80 21.73
2023-04-06 13G/A BlackRock Inc. 3.40 -59.57

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 81,090 404,970 20.02
2024-04-30 59,916 263,990 22.70
2024-04-29 153,586 278,494 55.15
2024-04-26 145,467 237,511 61.25

(click for more detail)

Similar Companies
ONCT – Oncternal Therapeutics, Inc. ONCY – Oncolytics Biotech Inc.
ONVO – Organovo Holdings, Inc. ORGS – Orgenesis Inc.
ORMP – Oramed Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io